California Public Employees Retirement System’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-16,300
Closed -$78K 3448
2017
Q1
$78K Sell
16,300
-800
-5% -$4.34K ﹤0.01% 3243
2016
Q4
$84K Sell
17,100
-800
-4% -$4.1K ﹤0.01% 3251
2016
Q3
$89K Sell
17,900
-1,400
-7% -$7.17K ﹤0.01% 3292
2016
Q2
$98K Sell
19,300
-700
-4% -$3.77K ﹤0.01% 3335
2016
Q1
$114K Sell
20,000
-1,300
-6% -$9.08K ﹤0.01% 3314
2015
Q4
$221K Hold
21,300
﹤0.01% 3158
2015
Q3
$393K Hold
21,300
﹤0.01% 2913
2015
Q2
$414K Hold
21,300
﹤0.01% 2979
2015
Q1
$360K Hold
21,300
﹤0.01% 3158
2014
Q4
$360K Hold
21,300
﹤0.01% 3158
2014
Q3
$268K Hold
21,300
﹤0.01% 3273
2014
Q2
$333K Hold
21,300
﹤0.01% 3210
2014
Q1
$305K Hold
21,300
﹤0.01% 3217
2013
Q4
$347K Sell
21,300
-890
-4% -$14.2K ﹤0.01% 3123
2013
Q3
$369K Buy
22,190
+2,400
+12% +$35.5K ﹤0.01% 2936
2013
Q2
$199K Buy
+19,790
New +$208K ﹤0.01% 3108

Other funds holding OSIR

California Public Employees Retirement System's OSIR Position: Q2 2017 in Review

California Public Employees Retirement System sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q2 2017, closing a stake of 16,300 shares — an estimated $78K sold.

California Public Employees Retirement System first reported a position in OSIR in Q2 2013 and held it in 16 quarters. The position peaked at $414K in Q2 2015. 3 funds tracked by Wall St. Rank hold OSIR as of Q2 2017.

  • California Public Employees Retirement System reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q2 2017 after selling out during the quarter.
  • California Public Employees Retirement System sold 16,300 Osiris Therapeutics, Inc. Common Stock shares in Q2 2017, an estimated $78K.
  • California Public Employees Retirement System first reported a position in Osiris Therapeutics, Inc. Common Stock in Q2 2013 and held it in 16 quarters.
  • California Public Employees Retirement System's Osiris Therapeutics, Inc. Common Stock position peaked at $414K in Q2 2015.
  • 3 funds tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q2 2017.

Based on California Public Employees Retirement System's 13F filing for Q2 2017, filed 11 Aug 2017.